Literature DB >> 7909708

Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites.

R T Gazzinelli1, E Y Denkers, A Sher.   

Abstract

Cell-mediated immunity (CMI) provides a major host defense against infectious disease and malignancy. Nevertheless, the mechanisms underlying the induction of CMI remain poorly understood and this lack of knowledge remains an important impasse in the design of rationally based vaccines and immunotherapies. Toxoplasma gondii is an intracellular pathogen that, as part of its normal life cycle, induces a potent CMI response leading to host resistance. Studies on the interaction of this parasite with the immune system therefore provide a unique approach for identifying events that selectively lead to the triggering of host-protective CMI. In addition, this knowledge may provide new strategies for immunotherapy of opportunistic infections in immunodeficient hosts.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7909708

Source DB:  PubMed          Journal:  Infect Agents Dis        ISSN: 1056-2044


  33 in total

1.  Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2.

Authors:  Chung-Dar Yang; Gan-Nan Chang; David Chao
Journal:  Parasitol Res       Date:  2003-11-06       Impact factor: 2.289

2.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Biochemical characterization and protein kinase C dependency of monokine-inducing activities of Toxoplasma gondii.

Authors:  E Grunvald; M Chiaramonte; S Hieny; M Wysocka; G Trinchieri; S N Vogel; R T Gazzinelli; A Sher
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

4.  Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection.

Authors:  N Debard; D Buzoni-Gatel; D Bout
Journal:  Infect Immun       Date:  1996-06       Impact factor: 3.441

5.  Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection.

Authors:  Kevin B O'Brien; Stacey Schultz-Cherry; Laura J Knoll
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

Review 6.  Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts.

Authors:  J P Dubey; D S Lindsay; C A Speer
Journal:  Clin Microbiol Rev       Date:  1998-04       Impact factor: 26.132

7.  The Transcription Factor T-bet Limits Amplification of Type I IFN Transcriptome and Circuitry in T Helper 1 Cells.

Authors:  Shigeru Iwata; Yohei Mikami; Hong-Wei Sun; Stephen R Brooks; Dragana Jankovic; Kiyoshi Hirahara; Atsushi Onodera; Han-Yu Shih; Takeshi Kawabe; Kan Jiang; Toshinori Nakayama; Alan Sher; John J O'Shea; Fred P Davis; Yuka Kanno
Journal:  Immunity       Date:  2017-06-13       Impact factor: 31.745

8.  A simple method to detect Toxoplasma gondii-specific cytotoxic T cells in vivo.

Authors:  Benjamin J Daniel; Srilakshmi Pandeswara; Michael J Brumlik; Aijie Liu; Suzanne R Thibodeaux; Sara M Ludwig; Xiuhua Sun; Tyler J Curiel
Journal:  J Immunol Methods       Date:  2010-02-08       Impact factor: 2.303

9.  Evaluation of a cyclic GMP-dependent protein kinase inhibitor in treatment of murine toxoplasmosis: gamma interferon is required for efficacy.

Authors:  Bakela Nare; John J Allocco; Paul A Liberator; Robert G K Donald
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

10.  Protective mucosal Th2 immune response against Toxoplasma gondii by murine mesenteric lymph node dendritic cells.

Authors:  Isabelle Dimier-Poisson; Fleur Aline; Marie-Noëlle Mévélec; Céline Beauvillain; Dominique Buzoni-Gatel; Daniel Bout
Journal:  Infect Immun       Date:  2003-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.